M. Docteur JEAN-CAMILLE MERIC
✨ Profil synthétique
IA · 06/05/2026Le Dr Jean-Camille Meric est un rhumatologue exerçant à Alès. Ses recherches portent principalement sur les maladies rhumatismales, notamment la polyarthrite rhumatoïde et les spondylarthropathies. Il a également contribué à des études sur le COVID-19 et les tendons.
Expertises présumées
- Polyarthrite rhumatoïde
- Spondylarthropathies
- Traitement aux anti-TNF
- COVID-19
- Pathologie tendineuse
- Thérapies anti-inflammatoires
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
4
h articles cités ≥ h fois chacun. Un h de 4 = 4 publications avec 4+ citations.
Citations
119
Publications
6
i10-index
3
Thématiques principales
- Rheumatoid Arthritis Research and Therapies ×3
- Spondyloarthritis Studies and Treatments ×3
- COVID-19 Clinical Research Studies ×1
- SARS-CoV-2 and COVID-19 Research ×1
- Tendon Structure and Treatment ×1
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Therapeutic Drug Monitoring of Infliximab in Spondyloarthritis: An Observational Open-Label Study
2011ArticleTher. Drug Monit.
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
2009ArticleFundamental & Clinical Pharmacology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Localisation
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieu de consultation
CABINET DU DR JEAN-CAMILLE MERIC
126 RUE ANDRE MALRAUX, 30100 Alès
☎ 0466523670Libéral© OpenStreetMap
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
Arthritis research & therapy · 2009
Lire l'abstract Crossref ↓
Abstract Introduction Adjustment of infliximab dosage for individuals may be useful in improving therapeutic response in rheumatoid arthritis (RA). Herein, we aimed to determine whether measurement of infliximab serum concentration modifies the therapeutic decision and improves the control of disease activity. Methods RA patients routinely treated with infliximab were included in an observational open-label study. On visit 1 (V1), according to the disease activity, a preliminary therapeutic decision was selected among four therapeutic options and a blood sample was collected to measure trough serum infliximab concentration. The final therapeutic decision, based on both disease activity and serum infliximab concentration assessed at V1, was applied at the following infusion (V2). Clinical and biological evaluations were performed at V3 and V4 and compared with those at V1. Results We included 24 patients. The final therapeutic decision differed from the preliminary decision for 12 patients (50%). For patients with increased infliximab dosage at V2, mean disease activity score for 28 joints (DAS28) decreased by about 20% at V3 or V4 as compared with V1 (P < 0.05). Decreased DAS28 was correlated with increased serum infliximab concentration (P < 0.02). Conclusions The measurement of infliximab trough concentration modifies the therapeutic decision for RA patients and helps improve control of disease activity. Therapeutic drug monitoring of infliximab in RA may be useful for individual dosage adjustment.
- 2Therapeutic drug monitoring of infliximab in spondyloarthritis: an observational open-label study
Therapeutic drug monitoring · 2011
📚 22 citations🩺 Clinique - 3Walking before an ultrasound assessment increases the enthesis score significantly
The Journal of rheumatology · 2011
Publications scientifiques (4) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Anti-TNF2
▼
Anti-TNF2
▼- Therapeutic drug monitoring of infliximab in spondyloarthritis: an observational open-label study
Therapeutic drug monitoring · 2011 · Clinical Trial
Méric JC, Mulleman D, Ducourau E, Lauféron F, et al.
📚 22 cit.🩺 Clinique - Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
Arthritis research & therapy · 2009 · Clinical Trial
Mulleman D, Méric JC, Paintaud G, Ducourau E, et al.
📚 57 cit.🎯 RCR 1.60🩺 Clinique
Transversal2
▼
Transversal2
▼- Walking before an ultrasound assessment increases the enthesis score significantly
The Journal of rheumatology · 2011 · Letter
Méric JC, Grandgeorge Y, Lotito G, Pham T
📚 14 cit.🔬→🩺 Translationnel - [Radiation-induced cataract: physiopathologic, radiobiologic and clinical aspects]
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique · 2001 · Journal Article
Belkacémi Y, Touboul E, Méric JB, Rat P, et al.
📚 12 cit.